|
|
News for Healthier Living
Dana-Farber Investigators Develop Protein Degrader Discovery Platform and Find First-in-Kind Metabolically Activated Molecular Glue Degrader
Investigators at Dana-Farber Cancer Institute have developed a platform for systematically discovering molecular glues that could become protein degradation drug candidates. The research builds on previous Ebert and Fischer lab findings that revealed the potential for molecular glue degraders to benefit patients with cancer.
August 5, 2026
August 6 2026 - Salmonella Outbreak Linked To Imported Jalapeños Sickens Hundreds
- Finding New Osteoarthritis Medicines Via AI and Genetics
- Wildfire Smoke Sends More Oregonians To Emergency Rooms
- Peanut Allergy? Fecal Transplant Might Be A Solution, Pilot Trial Finds
- New CDC Director Dr. Erica Schwartz Takes Over
- Three Midlife Habits That Could Help Protect Your Brain
- New research center set to explore treatments for Alzheimer's
- New U.S. Disease Tracker strengthens monitoring of vaccine-preventable diseases
- Protein 'Switch' Determines Whether Liposarcoma Cells Will Become Aggressive, Roswell Park Expert Reports
- Penn Nursing Professors Co-author Editorial on the Impact of Trauma, Stress, and Violence on Health
- Trial Focuses on Duration of Therapeutic Hypothermia for Out-of-Hospital Cardiac Arrests
- Research: Steam Increases Physiological Strain During Sauna Bathing
- A Drop That Can Save the Sight of Extremely Premature Babies
- From X Chromosome Silencing to Therapy: New Strategies for Treating X-Linked Disorders
- DXA Testing for Osteoporosis Screening Declined 35% Among Medicare Beneficiaries Over Nearly Two Decades
- Want Strong Bones? Review Says Vigorous Sports Like Handball Beat Walking, Strength Training
- Germs From Pet Dogs Might Protect Infants Against Infection, Researchers Say
- Parenting Can Offset ADHD Risk In Toddlers, Study Says
- Expert Shares Practical Tips for Treating Hair Loss
- Nurses Chase Cyclospora, Aided By Interviews, Fast-Food Receipts — And The Messy Details
- Innosuisse Flagship project for the prevention of type 2 diabetes
- Vascular and Musculoskeletal Interactions: Structure, Function, and Therapeutic Strategies for Sarcopenia and Osteoporosis
- Brain-body interactions in systemic diseases: a survey from an imaging perspective
- Essential genetic mutations impair DNA damage repair and modulate tumor immune microenvironment in ccRCC
- Proteogenomics: Decoding Cancer in Multiple Dimensions
August 5 2026August 4 2026August 3 2026August 1 2026July 31 2026July 30 2026July 29 2026July 28 2026July 27 2026July 26 2026July 25 2026July 24 2026July 23 2026
|
|
|
|
|